Surveillance of Complex Renal Cysts - the SOCRATIC Study

Last updated: January 28, 2025
Sponsor: Université de Sherbrooke
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Active surveillance

Surgery

Clinical Study ID

NCT04558593
2020-3522
  • Ages > 18
  • All Genders

Study Summary

One third of individuals aged >60 years will be diagnosed with at least one renal cyst following abdominal imaging. These cystic lesions are categorized according to the Bosniak classification which categorizes cysts according to their degree of complexity and risk of malignancy. Growing evidence suggests that a significant proportion of Bosniak III and IV cysts are benign and that the malignant ones present low metastatic potential. Since renal surgery carries substantial morbidity (20%) and potential mortality (0.5%), active surveillance has gained attention as a potential tradeoff to surgery to overcome overtreatment. Therefore, prospective studies of long-term follow-up are needed to confirm the oncologic safety of this strategy for patients with Bosniak III/IV cysts.

This is an multicenter prospective observational longitudinal study. The main objective is to compare the 5-year follow-up cancer-specific survival between the active surveillance and the surgical groups.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 18 years old and older;

  • diagnosed with a Bosniak III or IV cyst (classification 2019);

  • size of cystic component ≤7cm;

  • cyst wall/septum nodule (obtuse margin of protrusion) <10mm (perpendicular axis) ornodular/solid component ≤2 cm in any axis;

  • life expectancy >5 years (by physician's estimate);

  • new diagnosis ≤ 12 months from accrual date;

  • currently asymptomatic from the disease;

  • deemed fit enough for surgery;

  • willingness and ability to complete questionnaires in either French or English;

  • able and willing to provide informed consent

Exclusion

Exclusion Criteria:

  • history of a hereditary renal cancer syndrome;

  • presence of polycystic kidney disease;

  • any prior history of RCC;

  • received systemic therapy for another malignancy within the 12 months prior toaccrual;

  • uncontrolled medical illness including infections, hypertension, arrhythmias, heartfailure, or myocardial infarction/unstable angina within 6 months that wouldpredispose to immediate surgical therapy;

  • metastatic disease or evidence of vascular or nodal disease;

  • unwillingness to undergo monitoring and imaging studies;

  • any contra-indication(s) to contrast-enhanced imaging (estimated glomerularfiltration rate <30min/mL)

Study Design

Total Participants: 330
Treatment Group(s): 2
Primary Treatment: Active surveillance
Phase:
Study Start date:
February 02, 2021
Estimated Completion Date:
September 20, 2031

Study Description

Background: One in three patients over 60 years old will be diagnosed with a renal cyst following abdominal imaging. Traditionally, experts have recommended that complex cystic lesions (also known as Bosniak III - IV cysts) should be surgically removed, but recent evidences suggest that many are benign or have low metastatic potential. Thus, active surveillance which involves close follow-up of a patient's condition, was proposed as a tradeoff option to surgery.

Design: Multicenter observational longitudinal prospective cohort study

Objectives: The goal of this multicenter project is to conduct a prospective study with a 5-year follow-up to confirm the oncologic outcomes of active surveillance in the management of complex cysts. The main objectives are: 1) to compare the 5-year cancer specific survival between cysts managed by surgery and active surveillance; 2) to evaluate disease progression; 3) to evaluate patient's well-being according to each management strategy; and 4) to compare the 5-year healthcare cost of both management approaches.

Study population: Patients incidentally diagnosed with a Bosniak III and/or IV cysts, who are deemed to have at least 5 years of life, and who opted to be managed by either surgery or active surveillance. (N=330)

Follow-up: Patients will DECIDE if they want to have a surgery or to be followed by active surveillance. All patients will be followed as per standard of care with either semi-annual and annual visits. Research visits will serve to assess vital status and quality of life scores (through validated questionnaires). Patients on active surveillance will also be assessed for cyst progression and might be offered invasive or systemic therapy if progression is observed.

Connect with a study center

  • Prostate Cancer Center

    Calgary, Alberta T2V 1P9
    Canada

    Active - Recruiting

  • Northern Alberta Urology Center

    Edmonton, Alberta T6G 1Z1
    Canada

    Active - Recruiting

  • Vancouver Prostate Centre

    Vancouver, British Columbia
    Canada

    Active - Recruiting

  • Mens Health Clinic

    Winnipeg, Manitoba
    Canada

    Active - Recruiting

  • Nova Scotia Health Authority

    Halifax, Nova Scotia
    Canada

    Active - Recruiting

  • St-Joseph's Hospital

    Hamilton, Ontario
    Canada

    Active - Recruiting

  • The Ottawa Hospital

    Ottawa, Ontario
    Canada

    Active - Recruiting

  • Thunder Bay Health Sciences Center

    Thunder Bay, Ontario
    Canada

    Active - Recruiting

  • Princess Margaret Hospital

    Toronto, Ontario
    Canada

    Active - Recruiting

  • Woodstock hospital

    Woodstock, Ontario
    Canada

    Active - Recruiting

  • Centre intégré de santé et de services sociaux de Chaudière-Appalaches - Hôtel-Dieu de Lévis

    Lévis, Quebec G6V 3Z1
    Canada

    Active - Recruiting

  • CHUM

    Montreal, Quebec
    Canada

    Active - Recruiting

  • Hôpital Maisonneuve-Rosemont (CISSS-EIMtl)

    Montreal, Quebec
    Canada

    Active - Recruiting

  • McGill University Health Centre

    Montreal, Quebec
    Canada

    Active - Recruiting

  • CHU de Québec - Université Laval

    Québec, Quebec
    Canada

    Active - Recruiting

  • Centre de recherche du Centre hospitalier Universitaire de Sherbrooke

    Sherbrooke, Quebec J1H 5N4
    Canada

    Active - Recruiting

  • CHU Bordeaux

    Bordeaux,
    France

    Site Not Available

  • CHU Bordeaux (URO-CCR)

    Bordeaux,
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.